Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.

摘要: The purposes of this study were to determine the incidence hepatocellular carcinoma (HCC) in patients with chronic hepatitis or cirrhosis and assess cost benefit sonographic screening for HCC.We reviewed 647 sonograms 232 obtained over an 8-year period. One hundred fifty-two had at least two sonograms. fifty-four men 78 women a mean age 51 years included. Most (n = 207) biopsy-proven cirrhosis. Ethnicity, age, gender, type liver disease, alpha-fetoprotein levels analyzed factors associated HCC detection. costs sonography other tests calculated using Australian government Medicare benefits schedule.Thirty-one (13%) elevated levels. Liver masses found 25 (11%) patients. Six (2.6%) on biopsy 3) tests. All cases inoperable because tumor multicentricity metastases 2) both, t...